SCHEMBL29408989

SCHEMBL29408989

CC(C)(C)OC(=O)NC12CC(c3cc(-c4ccc(Cl)c(F)c4)on3)(C1)C2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOTUM Q6P988 2/20 0.39
▸ BDKRB1 P46663 2/20 0.36
▸ ATF4 P18848 3/20 0.35
▸ CNR2 P34972 1/20 0.35
▸ HDAC1 Q13547 3/20 0.35
▸ HDAC3 O15379 2/20 0.35
▸ HDAC2 Q92769 1/20 0.35
▸ HDAC8 Q9BY41 1/20 0.35
▸ HDAC6 Q9UBN7 3/20 0.35
▸ KMO O15229 1/20 0.34
▸ HDAC10 Q969S8 1/20 0.34
▸ NPC1 O15118 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ ABL1 P00519 1/20 0.34
▸ PDE4A P27815 1/20 0.34
▸ PDE4B Q07343 1/20 0.34
▸ PDE4C Q08493 1/20 0.34
▸ PDE4D Q08499 1/20 0.34
▸ LMNA P02545 1/20 0.33
▸ POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29408879 0.87 CDH1 (0.42) NOTUMHDAC1HDAC3HDAC2HDAC8
SCHEMBL22613960 0.85 KMO (0.41) NOTUMKMONPC1RAB9AABL1
SCHEMBL29408986 0.83 BDKRB1 (0.40) BDKRB1ATF4CNR2HDAC1HDAC8
SCHEMBL29409025 0.83 CNR2 (0.39) BDKRB1ATF4CNR2KMOABL1
SCHEMBL29499478 0.80 NR1H4 (0.36) NOTUMATF4HDAC1HDAC3HDAC2
SCHEMBL29408904 0.80 NR1H4 (0.36) NOTUMATF4HDAC1HDAC3HDAC2
SCHEMBL20722141 0.80 ATF4 (0.46) NOTUMATF4KMOPDE4APDE4B
SCHEMBL29409132 0.74 ATF4 (0.44) NOTUMATF4MAPTKMT2A
SCHEMBL29435971 0.74 ATF4 (0.44) BDKRB1ATF4
SCHEMBL29409061 0.73 ATF4 (0.47) ATF4KMOABL1PDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250145594-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ABBVIE INC. 2025-05-08 — — US disclosed
EP-4237413-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY Calico Life Sciences LLC (US) 2023-09-06 — — EP disclosed
WO-2022094244-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY CALICO LIFE SCIENCES LLC (US) 2022-05-05 — — WO disclosed
CN-114206848-A Substituted cycloalkyl compounds as modulators of integrated stress pathways 卡里科生命科学有限责任公司 2022-03-18 — — CN disclosed
EP-3962906-A1 SUBSTITUTED CYCLOALKYLS AS MODULATORS OF THE INTEGRATED STRESS PATHWAY Calico Life Sciences LLC (US) 2022-03-09 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250145594-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ATF4, ATF1, DDIT3 NOTUM 3811/4885BDKRB1 3371/4885ATF4 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback